Despite the moderate, well-demonstrated heritability of major depressive disorder (MDD), there has been limited success in identifying replicable genetic risk loci, suggesting a complex genetic architecture. Research is needed to quantify the relative contribution of classes of genetic variation across the genome to inform future genetic studies of MDD.
and Virginia Commonwealth University Experimental Research on Genetic Epidemiology) study of MDD was designed to reduce phenotypic and genetic heterogeneity by examining only severe cases and carefully screened control patients, all of whom were female and of Han Chinese ancestry. Using sparse whole-genome sequencing, we detected and replicated 2 common variants that contribute to MDD risk. 5 Not unexpectedly, these genome-wide significant loci accounted for only a small fraction of variance in MDD liability (approximately 0.6%). Given the polygenic nature of MDD, many additional loci likely contribute to disease risk but are of too small effect to attain genome-wide significance in our current sample. However, aggregate analyses of single-nucleotide polymorphism (SNP) data have proven instrumental in furthering our understanding of complex trait genetics. For example, support for the polygenic basis of schizophrenia was demonstrated by the predictive value of polygenic risk scores. 8 An alternative genome-wide approach derives narrow-sense heritability of quantitative traits by simultaneously considering all SNPs to estimate additive genetic variance. 9 The CrossDisorder Group of the Psychiatric Genomics Consortium used this approach to estimate SNP-based heritability of MDD at approximately 21%. 10 In addition, significant associations with polygenic burden of private disruptive mutations from wholeexome sequencing have been reported for psychiatric disease, including schizophrenia. 11 Here, we leverage advances in statistical methodologies to delineate the genetic architecture of MDD. Using genomic annotation databases, such as the Encyclopedia of DNA Elements, the enrichment of variants in regulatory elements and protein-coding regions can be assessed. 12, 13 Given our whole-genome sequencing data, enrichment of rare deleterious variants can also be tested. We apply an aggregate genetic risk method to estimate and partition heritability by chromosome, minor allele frequency (MAF), and various functional annotations as well as test for enrichment of rare deleterious variants. Our dense set of markers, which captures significantly more common and rare variation than is present on genotyping arrays, allows for a unique opportunity to add insight into the genetic architecture of this common and debilitating psychiatric disorder.
Methods

Sample Collection
Recurrent MDD cases were recruited from 58 provincial mental health centers and psychiatric departments of general medical hospitals in 45 cities and 23 provinces of China. Controls were recruited from several locations, including general hospitals and local community centers. All participants were Han Chinese women with 4 Han grandparents. Cases were aged between 30 and 60 years and had 2 or more episodes of MDD that met the criteria of the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition, Text Revision), 14 with the first episode occurring between ages 14 and 50 years; had not abused drugs or alcohol before their first depressive episode; and reported no history of schizophrenia or mania. Data collection took place from August 1, 2008 , to October 31, 2012. The study protocol was approved by the Ethical Review Board of Oxford University and the ethics committees of all participating hospitals in China. All participants provided written informed consent. Details on DNA sequencing and imputation of genotypes have been previously reported 5 and are summarized in the eAppendix in the Supplement.
Population Stratification
To address population stratification, we constructed 10 ancestry principal components (PC) using EIGENSOFT 3.0 and smartpca (Harvard University). 15, 16 To circumvent overfitting, we used only PC1 and PC2, which distinguished northsouth regional differences (eFigure 1 in the Supplement). Details appear in the eAppendix in the Supplement.
mate the contribution of each chromosome to the total heritability as well as to test for inflation due to cryptic relatedness, we constructed GRMs for each chromosome and estimated perchromosome heritability using each GRM separately and all GRMs jointly. We partitioned SNPs into MAF quintiles (0.005-0.50) and estimated the proportion of variance contributed by each quintile using the multicomponent GREML approach. To assess the relative contribution of heritability of SNPs in functional categories, we partitioned SNPs into functional annotations (eg, exon, intron, or 3′ UTR) using ANNOVAR, version 2015 (QIAGEN Bioinformatics). 18 The functional classes were fitted jointly in a single GREML model. To account for effects of uneven linkage disequilibrium, we applied the GCTA-LDMS 19 and the LDAK 17 approaches. In GCTA-LDMS, we calculated the linkage disequilibrium scores of all SNPs using a sliding-window approach (200 kB with 100-kB overlap between adjacent segments) and then partitioned them into linkage disequilibrium quartiles. Each linkage disequilibrium quartile was then partitioned into MAF quintiles, resulting in 20 GRMs that were fitted jointly. Using LDAK, we generated SNP weights that reflect a correlation with surrounding markers to construct GRMs adjusted for local linkage disequilibrium. For both methods, a relatedness filter (-grm-cutoff 0.05) was applied, giving a final sample of 10 474. We transformed the binary MDD disease status to the liability scale, assuming a prevalence of 8% (eAppendix in the Supplement). PC1 and PC2 were included as covariates.
Polygenic Risk Prediction
We constructed polygenic risk scores within CONVERGE by 2 methods. First, we randomly divided our sample (50-50 split) into independent subsets (sample 1 and sample 2). We conducted GWAS of each subset, subsequently performing linkage disequilibrium-based "clumping" to remove highly correlated markers (r 2 >0.1) while retaining the most significant SNP within 500-kB intervals. Using these linkage disequilibrium-independent SNPs, we computed per-individual polygenic scores on the basis of varying P value threshold signifying the proportion of SNPs with smaller P values in the training set; P value thresholds ranged from 0.001 to 1. 8 Second, using the sample 1-sample 2 split, we also estimated SNP effects by the best linear unbiased prediction (BLUP) method implemented in GCTA. 9 The latter scores were constructed with the profile option in PLINK, 20 using SNP BLUP solutions as weights.
We tested case-control differences by logistic regression with ancestry PC as covariates. The predictive value of these scores is reported in terms of Nagelkerke's pseudo-R 2 (fmsb package in R; package authored by Minato Nakasawa).
Enrichment of DNase I-Hypersensitive Sites
Studies have reported that SNPs with small P values, including those that do not reach genome-wide significance, are enriched for DNase I-hypersensitive sites (DHSs) in tissues related to the phenotype. 21 We obtained DNase peaks from the Encyclopedia of DNA Elements project data website (https: //genome.ucsc.edu/ENCODE/). We identified all SNPs with association P values with MDD less than threshold values (−log10[p] = 0, 0.5, 1, 1.5, …), and then we computed the proportion of SNPs lying in DHSs. To determine the statistical significance of any particular enrichment curve (ie, how unlikely under the null hypothesis of no enrichment), we assessed the statistical significance of enrichment on the intervals between -log10(p), between 5 and 6, and separately upward of 6 by binomial tests, and then we combined these P values by the Fisher exact method. We determined 95% CIs for enrichment curves by bootstrapping and assessed significance by empirical null distributions (eAppendix in the Supplement). 18 Variants of each annotation category and in each gene were aggregated for every individual and used in logistic regression as predictors of MDD, controlling for measures associated with sequencing runs, batch, read mapping quality, sequence coverage over the genome, GC (guaninecytosine) content, PC from the common variant analysis, and city of origin. Permutations were performed to verify that P values were not inflated (eAppendix in the Supplement).
Rare Variant Annotation and Enrichment Analysis
Results
MDD as a Polygenic Disease
Using approximately 4.7M autosomal and X chromosome SNPs, we estimated that 21.4% of the variance in MDD risk (95% CI, 15.5-27.3; P <1. 0×10 −16 ) is captured by genome-wide common variants (n = 10 474). eTable 1 in the Supplement shows heritability estimates based on varying MDD prevalence, which increases with higher prevalence rates. The variance in MDD explained by each chromosome was proportional to its length (r = 0.680; r 2 =0 .463;P = .0003). Heritability estimates for separate vs joint analyses of all chromosomes indicated a negligible effect of confounding population structure (joint h 2 = 21.4%; separate h 2 = 23.6%) (eFigure 2 in the Supplement). To assess the relative contribution of MAF to heritability estimates, we partitioned SNPs into MAF quintiles. Higherfrequency SNPs (>19%) accounted for most of the heritability ( Figure 1 ). As we are using imputed SNPs and therefore a denser set of markers than on genotyping arrays, we accounted for the biasing effect of uneven linkage disequilibrium by 2 methods. eTable 2 in the Supplement shows results for GCTA-LDMS, which partitioned heritability by linkage disequilibrium quartile and MAF to correct for region-specific linkage disequilibrium heterogeneity and indicated minimal bias in our unstratified heritability estimate of 21.4% vs 20.0% (SE = 3.4%) for LDMS. An alternative approach using LDAK, which accounts for local linkage disequilibrium by weighting all SNPs on the basis of correlations with surrounding SNPs, estimated heritability at 29.4% (SE = 4.6%; P =9.09×10 −11 ).
Polygenic Risk Prediction
Polygenic risk scores significantly predicted MDD disease status (eTables 3 and 4 in the Supplement). We attained the greatest predictive power using BLUP solutions (eTable 4 in the Supplement); this score was associated with MDD (P <4. 6×10 −5 ), accounting for 1.1% of the variability in MDD risk. When applying the P value threshold method, we attained the greatest predictive ability using P(t)<0.4; this score was associated with MDD (P <3. 0×10 −6 ), accounting for 0.55% of variability in MDD liability (eTable 3 in the Supplement).
Functional Variant Contribution to MDD
To assess the contribution of heritability due to SNPs in coding vs noncoding regions, we partitioned SNPs into their proposed genic annotations. When partitioning SNPs into 3′-UTR, 5′-UTR, exonic, and intronic regions, those in introns and 3′ UTR were significantly enriched for disease-relevant effects ( Figure 2A ). Considering the total number of SNPs in each functional category relative to the aggregate variance explained, the pattern of findings suggests that 3′-UTR effects may be particularly important to the etiology of MDD ( Figure 2B ). 
Enrichment of SNPs in DHS
We find enrichment of SNPs with low P values associated with MDD in DHS of many cell types, including brain-related tissues. Figure 3 shows the enrichment curves for DHS annotated in 1 brain sample with bootstrap confidence intervals. 22 With our finding of loci near a gene with mitochondrial functions (SIRT1, an NAD+-dependent histone deacetylase and a mitochondrial ion transporter), 5 we inquired whether singleton deleterious mutations would be enriched in nuclear-encoded genes with mitochondrial localized gene products. A significant enrichment in deleterious variants in nuclearencoded mitochondrial genes (OR, 1.075; 95% CI, 1.018-1.135; P = .009) was found. We then applied a permutation-based method to investigate whether the ORs were significantly different from the average gene genome-wide value. We randomly selected an amount of coding DNA equal in length to that used when the analysis is restricted to genes expressed in the brain and in nuclear-encoded mitochondrial genes and then repeated the analyses 10 000 times. The empirical P value was .04 for the OR observed in the brain-expressed gene set and was .02 for that in the nuclear-encoded mitochondrial genes (eFigure 7intheSupplement). Because these tests explore whether the 2 ORs are significantly different, we applied a Bonferroni corrected threshold of 0.025 (0.05/2).
Discussion
We extended our work in CONVERGE beyond identifying specific risk variants by evaluating aggregate contributions of molecular variation to risk for MDD. There are several noteworthy conclusions. First, we estimated the lower bound of narrow-sense heritability as between 20% and 29% depending on the method applied and the assumed MDD prevalence. Although these estimates were similar to those reported for populations of European descent (approximately 21%) 10 but lower than the 37%
reported by previous twin studies, 3 heritability is a population- Enrichment curve for "FrontalCortexOC" is a Loess curve interpolating the ratio of the number of single-nucleotide polymorphism (SNPs) whose association P value is smaller than various thresholds (x-axis) to the proportion of P values from all measured SNPs in DNase I-hypersensitive sites smaller than the same thresholds. The dark and light blue areas display 50% and 95% CIs, respectively, obtained by bootstrapping SNP sets.
specific measure. Our results apply to Han Chinese women, aged between 30 and 60 years, with recurrent depression. Second, our results support a substantial polygenic component to the risk of MDD involving many alleles of individually very small effect. Genome-wide polygenic risk scores constructed from SNPs were significantly associated with MDD liability, accounting for 1.1% of the variance in risk compared with 0.6% estimated by a similar method for European samples. 23 Significant heritability was found across all chromosomes, with the amount of variance explained proportional to length, further demonstrating an underlying polygenic architecture of MDD. It has been suggested that common variants have a smaller role in the etiology of MDD than originally posited by the common-disease-common-variant hypothesis because of the low proportion of variance explained by earlier GWAS. 24 ,25 However, we found that the bulk of detectable heritability comes from common variants (MAF>0.19, the 2 topmost quintiles). This finding contrasts with the finding of a similar analysis carried out on a large schizophrenia cohort, in which heritability was distributed more evenly across the quintiles. 26 The excess of heritability attributable to the most common MAFs is, in part, possibly because the small reduction in reproductive fitness associated with mood disorders exerts little selective power to drive risk variants to lower allele frequency.
27,28
We found that particular functional categories of the genome contribute disproportionately to the heritability of MDD. Specifically, SNPs in genic regions, especially those in introns and 3′ UTR, explain more variance than in noncoding regions. We also found an enrichment of SNPs in DHSs, which mark transcriptionally active regions of the genome, in several tissue types, including brain tissue. Recently, Finucane et al 29 have reported enrichment of functional elements in 17 complex traits and diseases, including 3 psychiatric disorders. They found significant enrichment in coding regions for schizophrenia and bipolar disorder as well as enrichment in 3′ UTR for schizophrenia. Performing a similar analysis on depressive symptoms, Okbay et al 30 also
reported enrichment of SNPs in DHSs but did not find enrichment of intron or 3′-UTR sites.
Regarding enrichment of DHSs, several other tissues, including the liver and pancreas, showed enrichment comparable to brain tissue. We propose 2 explanations for this finding. First, it is possible that DHSs are enriched in tissues other than brain tissue given that we have prior evidence of the role of genes with mitochondrial function in MDD, 5 metabolism is regulated in many tissues, and many regulatory mechanisms are common to many tissues. Second, regulatory elements in brain cells are harder to identify by DHS because of greater celltype heterogeneity than is found in most somatic tissues.
We report for the first time, to our knowledge, that, compared with controls, MDD cases had significantly more singleton deleterious SNPs in exons than controls. Similar results have been found for schizophrenia. 11 We also showed that variation in nuclear-encoded mitochondrial genes contributes to the risk of MDD. Notably, MDD is reported as a comorbid illness in some human mitochondrial diseases, including those arising from mutations in genes that regulate mitochondrial DNA integrity; for example, depressive episodes are reported in patients who carry mutations in POLG1 (OMIM 174763). 31 The identification of mitochondrial genes as risk factors for MDD might also explain some clinical features of the illness. For example, SIRT1 (OMIM 604479) influences processes that feature among the vegetative symptoms 32 of MDD: alterations in food intake, 33 wakefulness, 34 and circadian rhythms. 35 The involvement of mitochondrial genes might also explain why MDD increases the risk of cardiovascular disease.
36
Design elements of CONVERGE sought to reduce genetic and phenotypic heterogeneity. Cases were recurrent and quite severe, with approximately 85% meeting the criteria for melancholia. An important theoretical question is the expected pattern of findings if we selected a more homogeneous and more severely ill cohort. We are guided by the only empirical study we know regarding this question. Using population-based female twins, Kendler 37 tested a multiple-threshold model in which melancholia exists as a more severe form on the same continuum of liability as nonmelancholic MDD. This model fit the data well, and the heritability of melancholia was not different from nonmelancholic MDD, as expected under the liability threshold model. Based on these findings, we predict that the heritability of MDD in CONVERGE would not differ substantially from other samples, but the CONVERGE sample, in general, and our melancholic cases, on average, would have higher genetic liability. While SNP-based heritability estimates for melancholic and nonmelancholic MDD were not significantly different (eTable 6 in the Supplement), polygenic risk scores were more predictive of melancholic rather than nonmelancholic MDD (P = .002) (eTable 7 in the Supplement).
Conclusions
Our results are consistent with a polygenic architecture for MDD. A significant proportion of variance was due to common variants, although rare variation also appears to contribute to MDD disease liability. The genome partitioning results presented here provide direction for functional follow-up and will inform future studies. Taken together, our results support a complex etiology for MDD and highlight the value of partitioning heritability to better delineate the genetic architecture of this common, disabling psychiatric disorder. 
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eAppendix. The Genetic Architecture of Major Depressive Disorder in Han Chinese Women
DNA sequencing and imputation of genotypes
Detailed methods for sequencing and genotype imputation are described previously. 1 Briefly, DNA was extracted from saliva samples and sequencing reads obtained from Illumina Hiseq machines were aligned to the human genome. GATK 2 was used to perform base quality score recalibration, variant discovery, genotyping at all polymorphic SNPs in the 1000 Genomes Project East Asian (1KGP-ASN) haplotype reference panel (Phase 1, v3) , 3 and variant quality score recalibration using bi-allelic SNPs polymorphic in the 1KGP-ASN haplotypes as a true positive set. Genotype likelihoods (GLs) were calculated at selected sites using SNPtools. 4 
BEAGLE
5 was used to impute genotypes at those sites without a reference panel, and at all bi-allelic SNPs polymorphic in 1KGP -ASN using the 1KGP -ASN haplotypes as a reference panel. These two datasets were merged by dropping overlapping sites from the former dataset to generate a final set of allele dosages. Whole genome sequence was acquired to a mean depth of 1.7X (95% CIs 0.7-4.3) per individual from which 22781340 SNP sites were identified.
Population Stratification
To control for the effects of population stratification, ancestry principal components (PC) were estimated using EIGENSOFT 3.0 6 and SMARTPCA. 7 To correct for dependence between markers and avoid the potential disruption of the eigenvalue structure SNPs were pruned at r 2 > 0.02 prior to PC analysis. A total of 15,963 autosomal SNPs with Pr(G) ≥ 0.9, < 1% missing rate, MAF > 5%, and HWE > 10 -6 were used to generate 10 PCs. To circumvent over-fitting, 8 only PC1 and PC2, which distinguished north-south regional differences (Supplemental Figure 1) , were used in subsequent analyses.
We applied the LD-score regression approach 9 that was shown previously to distinguish polygenicity from confounding population stratification in the large PGC megaanalysis of schizophrenia.
10 Based on summary statistics for a filtered set of high-quality SNPs (imputation information > 0.9; MAF>0.01), we obtained estimates of and 1000 ( scaled to a sample size of 1000 cases and 1000 controls) of 1.077 and 1.014, respectively. The estimated LD-score regression intercept of 1.009, in the presence of genome-wide inflation of test-statistics, is taken to imply that this inflation is a signature of polygenicity rather than a confounding effect of population stratification or some other technical artifact.
Estimate of MDD population prevalence for SNP-based heritability analyses
Both GCTA and LDAK recommend the transformation of estimates to the liability scale for binary traits to account for scale and ascertainment bias. 11, 12 Population prevalence for MDD in China have been consistently lower than those commonly found in Western countries but have been increasing over the last two decades, probably as a result of increasing cultural acceptance. 13 Thus population based estimates of MDD in China are probably substantially downward biased due to false negative reports. Survey of the literature cites rates from 2-14%. 14, 15 Three recently obtained estimates of lifetime prevalence for MDD in China are i)

American Medical Association All rights reserved 3.6% for women from Shanghai and Beijing, 16 ii) 5.8% in women aged 45-59 (close in age to our CONVERGE cohort) in Beijing, 17 and iii) 6.5% in both sexes in Shenzen Province which would translate in estimates of 8-10% on women. 15 There is also a considerably higher point prevalence estimate in both sexes of 4.3% from Zhejiang province, immediately south of Shanghai. 18 The ratio of point to lifetime prevalence for MDD is probably around 3:1 or 4:1, 19 so the Zhejiang study, while something of an outlier, is consistent with a lifetime prevalence in both sexes of 12-15% and in females of around 20% --similar to that found in other countries. From the World Mental Health Survey, 29% of MDD cases report only a single lifetime episode (Kessler R, personal communication, 6/2/14) while 71% have recurrent illness. Given these range of considerations, we conservatively estimated that the true prevalence in China for MDD in women is ~ 12% of whom 8% would have recurrent illness and therefore meet criteria for CONVERGE. As such we have used k = 0.08 as our population prevalence parameter for GCTA and LDAK estimates. However, given the variability in national estimates for MDD we have included Supplemental Table 1 that reports snp-based heritability estimates (using GCTA) by varying population estimates (ranging from 2 to 20%).
Enrichment of DNaseI-hypersensitive sites (DHS)
In addition to the confidence intervals reported in the main text we also assessed statistical significance of enrichment by a separate method by constructing an empirical null distribution as follows. We generated 100000 random assignments of DHS to SNPs and then drew the enrichment curves against the log10 p-values. We measured the height of the curves at p = 10 -6 , a rough threshold for near-genome-wide significance, and then compared the heights of the observed curves, for various tissues, to these null curves. All analyses were performed in R 20 and code is available upon request. Note: The total sample was split into Sample 1 and Sample 2, MDD = major depressive disorder, pT = p-value threshold, R 2 Nagelkerke = Nagelkerke's pseudo-R 2 , R Note: Polygenic risk scores constructed from half of the sample (Sample 1) and tested in the remaining 50% (Sample 2), MDD = major depressive disorder, BLUP = best linear unbiased predictor, n = sample size, h 2 = SNP-based heritability estimate, R 2 = Nagelkerke's pseudo-R 2 , L-R 2 = liability scale R 2 , AIC = Akaike's information criterion, AIC = change in AIC relative to logistic model including only ancestry principal components (2). Enrichment curves as in Figure 3 (Main text) for all ENCODE samples as of July 2014. The numbers beside each tissue type (e.g. blood (12, 1.9) at top) are first: the number of samples of that type, and second: the mean of -log10(pval) for the enrichment in that tissue type; for blood the typical p-value is 10e-1.9 = .0126.)
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Calling rare exonic variants
All sequenced reads mapping to exonic regions of the human genome reference GRCh37.p5 passing a series of quality control were interrogated using SAMtools mpileup. 21 Read-pairs with both reads uniquely mapped, with mapping quality above 55, were included in this analysis. The exon coordinates were downloaded from the Ensembl release 67 Homo sapiens gtf file (ftp.ensembl.org/pub/release-67/gtf/homo_sapiens). The coordinates contained 96130824 base pair positions in 254986 exons in 21946 genes. Singletons (both SNPs and INDELs) were called when two or more reads supported the same alternative in a single sample. We chose a set of genes expressed in the brain (eGenetics/SANBI EST)  American Medical Association All rights reserved downloaded from biomart 22 for Ensembl release 75 February 2014. The expression data comes from ESTs in dbEST which were annotated with eVOC terms by SANBI 23 and sequence mapped to Ensembl gene predictions. A list of nuclear encoded mitochondrial genes was obtained from MitoCarta, 24 excluding three genes that overlapped with nuclear mitochondrial sequences from the hg19 NUMT track from UCSC. We calculated true positive rates for the called singletons by comparing with genotypes called in nine individuals for whom we also had 10X coverage. We assumed the singletons found in the same sample in both the low and 10X coverage data were true positives. We successfully amplified DNA at 64 deleterious variant sites, including 12 insertions and Sanger sequencing was obtained of each amplicon to validate the rare variant calls from next generation sequencing (Supplemental Material: Validation of rare variant calls). As we found good validation rate for SNP and deletion calls, but not insertions, we excluded all insertion calls from further analysis.
Validation of rare variant calls
We called only those variants detected by two or more reads in a single individual, using a custom code that counts the number of high quality reads supporting each allele at every variant position in the exome regions of the genome among all CONVERGE samples. As such, multiallelic sites were also taken into account, though only those alleles supported by two or more reads in a single sample, and occurring only in that sample, would be counted (Methods). Using this approach, we identified 302838 rare coding SNPs and insertiondeletion polymorphisms (INDELs). Supplemental Figure 4 shows the distribution of number of samples with more than two reads at singleton sites we discovered, and the graph below it shows the cumulative percentage of singleton sites with more than each percentage of samples having 2 reads covering it. The mean number of samples having more than 2 reads at a singleton site is 4126 (38.8% of the whole sample), corresponding to an allele frequency of 0.024%.
As this analysis was based on hard filters for high quality sequencing reads, and counting of number of reads supporting each private allele, there were concerns regarding the true positive and false positive rates of variant calling, therefore affecting the validity of using these variants for any further analysis. We therefore compared the positions and alleles called at private variants sites in nine samples for whom there were 10X coverage sequence data. This comparison estimated a true positive rate of 96.5% for SNPs and 97.2% for INDELs (Supplemental Table 5 ), while none of the private variant calls were false positives. The false negative rate, however, was very high, as requiring two reads support of 1x coverage sequencing for a private variant is a very stringent filter that most heterozygous sites, which are expected to make up most of the private variant sites, would not be able to fulfill. The false negative rate is 87.8%. 
Testing for private variant enrichment in MDD
There are a large number of hypotheses we could potentially test about the role of rare variants in the etiology of major depression -one could examine rare variants occurring at different frequencies, variants belonging to different annotation classes, classified using different algorithms, occurring in different gene sets and occurring in different diagnostic categories. Given the large sample size in CONVERGE but low sequencing coverage over the exome, and the high false negative rate in detection of private variants as a result, we could only test whether there are differences in the frequency of private variants in cases of MDD compared to controls.
The primary hypothesis was therefore threefold, in order of specificity: a) that private variants would be enriched in cases of MDD, b) private variants that cause coding changes could be enriched in cases of MDD, and c) private deleterious variants would be enriched in cases of MDD. A Bonferroni corrected p-value for this test is 0.05/3 = 0.0167. To classify the private variants based on their effect on coding and potential consequences to protein function, we annotated all the private variants using ANNOVAR (Methods), and defined as 'deleterious singletons' the sum of stop gain, stop loss, nonsynonymous, and frameshift deletion variants.
We then tested for differences in the frequency of private variants between cases of MDD and controls for four categories of variants: a) all variants, b) synonymous SNPs, c) non-synonymous SNPs, and d) all deleterious variants (including stop-gains, stop-losses and frameshift deletions). Insertion events were excluded because of the poor quality of our calls for this type of variant. While cases of MDD and controls did not differ significantly in sequencing metrics, including origin, ancestry (based on principal components), experimental batch and technical features of the sequencing (per gene coverage, GC content, and sequence quality), cases had significantly more singleton deleterious mutations than controls (p = 0.003 from logistic regression, Table 1 ).
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To confirm the p-values from the enrichment analyses were not inflated due to technical artifacts not yet accounted for, we ran a series of analyses in which the MDD case status was permuted. For each permutation of the MDD case status we obtained a p-value from logistic regression for the number of private variants per sample on the permuted MDD case status. We performed 10000 such permutations and logistic regressions to generate a distribution of p-values. Quantile-quantile plots were then generated to see if there was any deviation of p-values from the null distribution. These plots indicate no inflation of p-values (Supplemental Figure 6) . eFigure 6. Quantile-Quantile Plot for the Enrichment of Coding Private Variants in Cases of MDD. Each graph shows the expected association value (negative logarithm base 1) on the horizontal axis and the observed value on the vertical axis. Data are from 10000 permutations in which MDD case and control status has been randomly assigned. Plots are shown for all variants, and three annotation categories: non synonymous, synonymous, and deleterious variants. The latter are defined as the sum of stop gain, stop loss, nonsynonymous, and frameshift deletion variants, using annotation categories from ANNOVAR software.
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Private variant enrichment in brain and mitochondrial genes in MDD
Upon finding enrichment in deleterious variants in cases in all genes, we asked if we could narrow the sets of genes driving this enrichment by asking two further questions: a) is the enrichment present in variants occurring in genes expressed in the brain, as opposed to genes not expressed in the brain, and b) is the enrichment present in nuclear encoded genes whose protein products are exported to the mitochondrion? We therefore counted singleton deleterious mutations occurring in genes expressed in brain, not expressed in the brain, and those whose protein products were localized to the mitochondria. The Bonferroni corrected significant p-value for all three hypothesis, when applied on the four gene sets (including the original set containing all genes), is therefore 0.05/12 = 0.0042. Table 1 shows a significant (p = 0.004) excess of private deleterious mutations in cases for genes in expressed in the brain. In contrast, no significant enrichment was seen for associations between MDD and variants in genes not expressed in brain (p = 0.41).
While the choice for genes expressed in the brain is intuitive given MDD is a psychiatric disease likely to have neurobiological underpinnings in its etiology, we have previously found GWAS loci near two genes with mitochondrial functions, SIRT1 and SLC25A37.
1 This led to the inquiry of whether singleton deleterious mutations would be enriched in nuclear-encoded genes with mitochondrial localized gene products. 24 As the genes whose products are localized to the mitochondria may have "mitochondrial copies" in the mitochondrial genome similar in sequence, and in some cases encoding similar subunits for the same respiratory complexes, we intersected the list of nuclear encoded genes whose proteins are imported into the mitochondria with the nuclear mitochondrial (NUMT) loci from the hg19 NUMT track from UCSC, and found only three nuclear encoded genes contained NUMTs (these are: ENSG00000171612, ENSG00000132286 and ENSG00000102738), then excluded all three genes from the analysis. Table 1 shows a modest enrichment in deleterious variants in nuclear-encoded mitochondrial genes (p = 0.009), not passing the significance threshold after Bonferroni correction, but in the direction as expected.
To determine if the increase in the odds ratios attributable to deleterious variants in brain-expressed and nuclear-encoded mitochondrial genes was likely due to chance effects, we randomly selected a set of genes whose total coding length was equal to each gene set, and tested for enrichment in deleterious singletons, keeping case and control status unchanged in 10000 random selections. The empirical p-value for the odds ratio observed in the brain-expressed gene set was 0.035 and 0.017 for that in the nuclear-encoded mitochondrial genes (Supplemental Figure 7) , indicating that the enrichments are unlikely due to chance.
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American Medical Association All rights reserved eFigure 7. Enrichment of Singleton Variants in Gene Subsets. Empirical estimation of the odds ratio increase when singleton enrichment analysis is restricted to a subset of genes. The graphs show the empirical distribution of odds ratios obtained by randomly selecting an amount of coding DNA equal in length to that used when the analysis is restricted to nuclear encoded mitochondrial genes (upper figure) and genes expressed in the brain (lower figure) . Horizontal axes show odds ratios and the vertical axis the frequency with which an odds ratio occurs in 10000 analyses. The vertical red lines are the observed odds ratios from analyzing enrichment of singleton variants in MDD cases. Gene sizes were calculated using data from Ensembl release 77 October 2014 downloaded from ftp://ftp.ensembl.org. Note: Polygenic risk scores (PRS) constructed from half of the sample and tested in the remaining 50%, MDD = major depressive disorder, BLUP = best linear unbiased predictor, n = sample size, non-MEL = MDD cases that do not meet criteria for melancholia (~15% of MDD cases), MEL = melancholia (85% of cases), est = partial regression coefficient for PRS, SE = standard error, p = p-value, R 2 = Nagelkerke's pseudo-R 2 .
